DHCClass II
System, Test, Systemic Lupus Erythematosus
21 CFR 866.5820 / Immunology
DHC is the FDA product code for System, Test, Systemic Lupus Erythematosus, a class II device type, regulated under 21 CFR 866.5820. As of , FDA records hold 16 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- DHC
- Device name
- System, Test, Systemic Lupus Erythematosus
- Regulation
- 21 CFR 866.5820
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 16
- Ingested recalls
- 1
Clearances, product code DHC
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1979 | 3 |
| 1980 | 3 |
| 1981 | 2 |
| 1982 | 1 |
| 1987 | 1 |
| 1989 | 1 |
| 1991 | 1 |
| 1993 | 2 |
| 2001 | 2 |
Applicants with the most clearances
Product code DHC| Applicant | Clearances |
|---|---|
| Cordis US Corp. | 2 |
| Corgenix, Inc. | 2 |
| Icl Scientific | 2 |
| Armkel, LLC | 1 |
| Biologics Intl., Inc. | 1 |
| Elias U.S.A., Inc. | 1 |
| General Biometrics, Inc. | 1 |
| Immuno-Products Industries | 1 |
| Immunostics, Inc. | 1 |
| Lipogen, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
